688566 Jiangsu Jibeier Pharmaceutical Co., Ltd.
- 20.95
- +0.43+2.10%
Jiangsu Jibeier Pharmaceutical Co., Ltd. News
Gibel\'s announcement on adjusting the implementation plans of some of the company\'s fund-raising investment projects
Verification Report of Xinyong Zhonghe Certified Public Accountants (Special General Partnership) on Jiangsu Gibel Pharmaceutical Co., Ltd.\'s pre-investment in fund-raising investment projects with self-financing
Announcement from Jiangsu Jibeier Pharmaceutical Co., Ltd. regarding the opening of a dedicated settlement account for financial products.
Announcement of Progress in Litigation Matters and Receipt of Retrial Application Ruling by Jiangsu Jibeier Pharmaceutical Co., Ltd.
Jiangsu Jibeier Pharmaceutical Co.,Ltd.'s "Articles of Association" (Revised in June 2024).
Announcement regarding the amendment of registered capital and modification of the company's articles of association by Jiangsu Jibeier Pharmaceutical Co., Ltd.
Jiangsu Jibeier Pharmaceutical Co., Ltd. Announces the Signing of Triple Supervision Agreement for Fundraising.
Announcement of resolutions of the 2023 Annual General Meeting of Shareholders of Gibbel
Legal Opinion of Beijing Jindu (Nanjing) Law Firm on the 2023 Annual General Meeting of Shareholders of Jiangsu Gibel Pharmaceutical Co., Ltd.
Jiangsu Gibel Pharmaceutical Co., Ltd. 2023 Annual General Meeting of Shareholders Meeting Materials
Gibel's announcement on holding a briefing on the results and cash dividends for the first quarter of 2023 and 2024
Gibel's announcement on requesting the shareholders' meeting to extend the authorization for the board of directors to issue shares to specific targets through simple procedures
Jiangsu Gibel Pharmaceutical Co., Ltd. 2023 Internal Control Evaluation Report
Report on the performance of the Audit Committee of the Board of Directors of Jiangsu Gibel Pharmaceutical Co., Ltd. 2023
Special report of the board of directors of Jiangsu Gibel Pharmaceutical Co., Ltd. on the self-inspection of the independence of independent directors
Report on the performance of supervisory duties by the Audit Committee of the Board of Directors of Jiangsu Gibel Pharmaceutical Co., Ltd. on the accounting firm
Jiangsu Jebel Pharmaceutical Co., Ltd. 2024 “Improve Quality, Increase Efficiency and Value Return” Action Plan
Gibel's Notice on Convening the 2023 Annual General Meeting of Shareholders
Gibel's announcement on amending the “Articles of Association”
Gibert's “Articles of Association” (revised in April 2024)
Analysis
Price Target
No Data
